Print ISSN 1234-5678

1. Purpose
  • This regulation aims to publish an article in Research in Clinical Pharmacy(RCP) of Asian Conference on Clinical Pharmacy(ACCP).
2. Publishing Date
  • Articles are published biannually and the publication dates are June 30th and December 30th.
3. Publishers and Editors
  • The publisher of RCP shall be a president of ACCP and the editor shall be the editor in chief.
4. Article types
  • RCP publishes a variety of article types as follows.
    • - Original articles: original research reporting original analyses of data that improves clinical decision making (maximum word count: 4,000)
    • - Reviews: a review article that provides a narrative up-to-date review on a topic for clinicians
    • - Case study: case study/case series reports an interesting clinical case that provides insights to clinical decision making
    • - Commentary and Perspectives on current clinical topics
    • - Education: A professional journal describing current education of clinical pharmacy
    • - Systemic review/Meta-analysis: systematic review with or without meta-analysis that synthesizes evidences of a specific clinical topic
5. Copyright and Reuse
  • Copyrights for articles submitted are automatically attributed to RCP. If authors wish to reproduce their articles in elsewhere, authors must request a permission to RCP in prior.
6. Publishing Order
  • Journals shall be published after reviewing the submitted manuscripts strictly according to Reviewers Guideline. Journals shall be published in the order of the first submission date.
7. Responsibility for Article
  • In the case of a manuscript that has been reviewed and confirmed to be published according to the decision of the editorial committee, authors shall confirm a final manuscript and is responsible for the article.

Asian Conference of Clinical Pharmacy follows the publication ethics guideline recommended by International Committee of Medical Journal Editors (ICMJE, http://www.icmje.org/) and Committee of on Publication Ethics (COPE, https://publicationethics.org/).

  • 1. All submitted manuscripts should be original. The manuscript should not be simultaneously submitted to more than one journal. If the manuscript is overlapped with one already published, it will be considered as a duplication. Duplicate submission is an act of violation of an international copyright laws, ethical conduct, and cost-effective use of resources. When authors submit a manuscript that has already been published or is contained in or closely related to another paper, a notice to authors and the announcement in our journal and to relevant institution will be informed. A penalty regarding the violation will be discussed among the editorial board members.
  • 2. Scientific misconducts are not only confined to data fabrication, plagiarism, and purposeful failure to disclose relationship and activities but also failure to publish the results of clinical trials and other human studies a form of scientific misconduct. If any ethical issues mentioned above occur, the editorial board members will review the issue and make a decision according to ethic guidelines.
  • 3. When conducting a study with an animal, authors should clarify the standards for the care and use of laboratory animals were followed. According to ICMJE, a suggested guidance on animal research ethics is available from the International Association of veterinary Editors’ Consensus Author Guidelines on Animal Ethics and Welfare (http://www.veteditors.org/consensus-author-guidelines -on-animal-ethics-and-welfare-for-editors).
  • 4. If a violation in the publication ethics of journal is detected, the issue should be reported to the editorial board. The editorial board Committee will promptly review and discuss about the issue according to guidelines.
  • 1. Aim Editorial board is gathered to helping the journal Research in Clinical Pharmacy ensure the highest quality of the journal via thorough review process and further dedicate to the development of clinical pharmacy practice.
  • 2. ResponsibilityThe editorial board shall be responsible for editing and publication of journals.
    • - The editor oversees the aim, mission, and scope of the journal with authors and ACCP board members to achieve the final goals of RCP.
    • - The editor is responsible to set the timely, thorough, and systemic review process for assure the quality of RCP.
    • - The editor ensures the article is new in findings and follows the ethical policies of RCP.
    • - Editorial Boards can evaluate the editorial board members according to their contributions every year and updates the editorial team regularly. An Editorial Board member can step down from the position at any time if he or she feels overloaded by the requests.
  • 3. Editorial Board Appointment and Composition
    • - Editorial board consists of editor-in-chief, deputy editor, associate editors, and editors from each country.
    • - Editors are clinical pharmacy practitioner, faculty member of school of pharmacy, and other healthcare professionals.
    • - Editor-in-Chief (EiC) is recommended by ACCP president and approved by the board members. EIC determines the journal's aims and scope, formulate and revise practicable publication plans and goals for the journal’s development, invite distinguished researchers to join the Editorial Board, suggests topics for special Issues and providing advice for input or feedback regarding new regulations on the journal.
    • - Deputy Editor (DE) is recommended by Editor-in-chief and appointed by ACCP president. DE is responsible for the preliminary assessment and scrutiny of a manuscript in coordination with the Associate Editors.
    • - Associate Editors (AE) are recommended by Editor-in-chief and appointed by ACCP president. AE are managing editors who commissions articles by evaluating the suitability of a manuscript given the stated aims and scope of the journal, observes the match between the author’s institutional affiliation and the area of research, and rejects or forward the manuscript for a thorough review process.
    • - Editors are a group of representatives from each country and appointed by ACCP president. All editors shall submit a resume containing their research achievements. Editors are distinguished researchers in the field of clinical pharmacy from major academic institutions and pharmacy practice sites around the world.
    • - Managing Editors (ME) is appointed by EiC and is responsible for directly handling day-to-day operations of the publication's editorial activities.
  • 4. Term The term shall be three years but can serve consecutive terms.
  • 5. Manuscript Review The submitted manuscripts are reviewed by the editors and final publication decision is determined by the editorial board, associate editor, and editor-in-chief.
  • 6. Editorial board meeting Editorial board meetings shall be held annually, or more often when the EiC feels needed.
  • 7. Publication of journal Research in Clinical Pharmacy journal shall be published twice a year.
  • 8. Archives of journal
    • - Documents related to the review of submitted manuscript shall be kept for two years from the completion of the review.
    • - Archives of journal are kept and uploaded on the journal website.